ArticleEndoscopy international open2026
Precision vs. cost: Endoscopic ultrasound-guided vs. conventional pancreatic cyst drainage in a resource-limited setting.
Article in Endoscopy international open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and study aims: Pancreatic pseudocyst is a frequent complication of pancreatitis. Endoscopic ultrasound (EUS) being the standard approach for drainage, along with conventional transgastric (CTG) remains an alternative, but comparative real-world data from resource-limited settings remain scarce. Patients and methods: A retrospective review was conducted at a tertiary-care center in Pakistan from 2015 to 2025. Patients undergoing pseudocyst drainage via CTG or EUS were compared for demographic variables, technical success, complications, and procedure costs. Logistic regression was used to identify predictors of either modality for drainage. Results: A total of 164 patients underwent pseudocyst drainage, including 96 (58.5%) treated with EUS-guided drainage and 68 (41.5%) with CTG. Mean age was 32.76 ± 16.65 years (range 4-77), with 42 pediatric patients. Abdominal pain was the most common presenting symptom. Pseudocysts treated with CTG were significantly larger than those treated with EUS (15.02 ± 8.20 mm vs. 8.49 ± 2.53 mm; Conclusions: EUS-guided and conventional transgastric drainage demonstrate comparable safety and efficacy. In resource-limited settings, CTG remains a cost-effective option in appropriately selected patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.